Carvolix SA (EPA:CVX)
France · Delayed Price · Currency is EUR 3.360
+0.080 (2.44%)
Jun 5, 2026, 5:35 PM CET
Carvolix Market Cap
Carvolix has a market cap or net worth of €199.06 million as of June 5, 2026. Its market cap has increased by 253.77% in one year.
Market Cap
199.06M
Enterprise Value
217.13M
Revenue
900.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.36
Market Cap Chart
Since June 14, 2021, Carvolix's market cap has increased from 145.31M to 199.06M, an increase of 36.99%. That is a compound annual growth rate of 6.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 199.06M | 192.42% |
| Dec 31, 2025 | 68.07M | 28.15% |
| Dec 31, 2024 | 53.12M | -6.82% |
| Dec 29, 2023 | 57.01M | 86.82% |
| Dec 30, 2022 | 30.52M | -70.47% |
| Dec 31, 2021 | 103.35M | -28.88% |
| Jun 14, 2021 | 145.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 220.50M |
| Median Technologies | 202.12M |
| Guerbet | 130.69M |
| Theraclion | 51.10M |
| Novacyt | 35.11M |
| Mauna Kea Technologies | 33.05M |
| Diagnostic Medical Systems | 31.86M |
| Implanet | 26.32M |